of illness, which results in the 290 000 to 650 000 deaths worldwide annually. Although rapid
diagnostic tests are majorly used, PCR based techniques are being adopted for detection of
influenza.
According Report on Global Sexually Transmitted Infection Surveillance published in 2015 by
WHO, in 2012, an estimated 357 million new infections, which is equivalent to roughly 1
million patients per day were reported for the four curable sexually transmitted disease such as
chlamydia, gonorrhea, syphilis, and trichomoniasis.
Furthermore, advances in anti-viral therapy in terms of detection techniques, medication, and
vaccines are expected to drive the virology testing market growth. Worldwide efforts are going
on to find novel vaccines and novel medication for treating viral resistant diseases. For
instance, Pritelivir is investigational drug for herpes simplex virus (HSV) by AiCuris has proven
to be very effective as compared to the current standard antiviral treatments for genital herpes
in Phase II trials. Extensive research has been conducted worldwide for treatment of high
epidemic viral disease such as Ebola, Dengue, and Malaria.
New technologies for detecting and curing viral disease could help in market expansion. For
instance, the nanoscale viral trap molecule technology, which is under research at present can
be applicable in diagnosing a viral disease. An innovative tunable device selectively traps
viruses detecting them with 100 times better sensitivity than the current available techniques.
Double-stranded RNA Activated Caspase Oligomerizer (DRACO) is another nanoparticle based
drug in research to treat viral disease.
Advancement in diagnostic technologies from culture based methods to nucleic acid and
molecular diagnosis techniques is leading to new product launches by key players, which is
expected to drive growth of virology testing market. For instance, Roche in 2017, launched
cobas HPV Assay to be performed on the cobas 6800/8800 Systems. Cobas HPV assay aids in
identifying women at risk of cervical cancer, performed on cobas 6800/8800 Systems which is
fully automated system with capacity to deliver large diagnostic services.
Report includes chapters which deeply display the following deliverable about industry :
• Virology Testing Market Research Objective and Assumption
• Virology Testing Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Virology Testing Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis